AGO3 and AGO4 identified as required for meiotic sex chromosome inactivation in male mice

Researchers led by Paula E. Cohen and colleagues at Cornell University have published a study in PLOS Genetics demonstrating that Argonaute proteins AGO3 and AGO4 — but not the more studied AGO2 — localise to the sex chromatin of pachytene spermatocytes and are required for Meiotic Sex Chromosome Inactivation (MSCI).

MSCI is the process by which XY-linked genes are transcriptionally silenced during the pachytene stage of male meiosis. Failure of this silencing is associated with spermatogenic arrest and male infertility in mice. The new work shows that AGO3 and AGO4 are not simply carrying out the microRNA-mediated post-transcriptional gene silencing for which Argonaute proteins are best known; instead, they are acting at the chromatin level to enforce transcriptional silencing of sex-linked genes.

The paper also reports that AGO proteins influence the timing of the broader spermatogenic transcriptional programme — the ordered sequence of gene expression changes that accompanies sperm cell maturation. The findings position a subset of Argonaute proteins as regulators of germline genome architecture, distinct from their canonical cytoplasmic roles, and open questions about whether analogous mechanisms operate in other contexts requiring sex-chromosome dosage compensation.